Article Text
Editorial commentary
Geographical differences in preventative therapies for neuromyelitis optica spectrum disorder
Statistics from Altmetric.com
Footnotes
Contributors MM has made a draft of the manuscript and AU and SK have supervised it.
Funding This work was supported in part by the Health and Labour Sciences Research Grant on Intractable Diseases (Neurodegenerative Diseases) from the Ministry of Health, Labour and Welfare of Japan.
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.